Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
John Creecy
AddedMar 31, 2024
UpdatedMay 31, 2026
John Creecy

John Creecy

Board Member, Remeditex Ventures

Crunchbase

John Creecy's Career

Remeditex Ventures
Remeditex Ventures

Dallas, TX, US

Board Member· Board
Quartet Medicine
Quartet Medicine

Cambridge, MA, US

Board Member· Board
Peloton Therapeutics
Peloton Therapeutics

Dallas, TX, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

John Creecy's Career

Remeditex Ventures
Remeditex Ventures
Investment FirmInvestment Firm82011Dallas, TX, US
Board Member· Board

Leadership at Remeditex Ventures

Dennis Keith StoneDennis Keith StoneBoard Member
Brett RingleBrett RingleBoard Member

Similar to Remeditex Ventures

Advent Venture PartnersAdvent Venture PartnersLondon, Greater London, GBest. 2002Advent Venture PartnersLondon, Greater London, GB · est. 2002

Advent Venture Partners: A UK-based venture capital firm investing in life sciences and technology.

Investment Firm34
Red Tree Venture Capital.Red Tree Venture Capital.Portola, CA, USest. 2020Red Tree Venture Capital.Portola, CA, US · est. 2020

Red Tree Venture Capital: Investing in early-stage life sciences companies.

Investment Firm7
Empath VenturesEmpath VenturesLos Angeles, CA, USest. 2021Empath VenturesLos Angeles, CA, US · est. 2021

Empath Ventures: A Los Angeles-based venture capital firm, investing in psychedelic medicine since 2021.

Investment Firm8
PTV Healthcare CapitalPTV Healthcare CapitalAustin, TX, USest. 2003PTV Healthcare CapitalAustin, TX, US · est. 2003

PTV Sciences LP: A global venture capital firm investing in healthcare and life sciences.

Investment Firm10
Quartet Medicine
Quartet Medicine
Series A$23M72013Cambridge, MA, US
Board Member· Board

Leadership at Quartet Medicine

Mark H N CorriganMark H N CorriganBoard Member
Gerhard KoenigGerhard KoenigBoard Member
Bruce BoothBruce BoothBoard Member
Henry B. SkinnerHenry B. SkinnerBoard Member
Kevin PojasekKevin PojasekFounder
Peloton Therapeutics
Peloton Therapeutics
Acquired$242.6M02010Dallas, TX, US
Board Member· Board

Leadership at Peloton Therapeutics

David GoeddelDavid GoeddelBoard Member
David ChangDavid ChangBoard Member
Michael S. BrownMichael S. BrownCo-Founder
Tim KutzkeyTim KutzkeyBoard Member
Steven McKnightSteven McKnightCo-Founder
Helen S KimHelen S KimBoard Member

Similar to Peloton Therapeutics

Pelican TherapeuticsPelican TherapeuticsBoca Raton, FL, USBiologic Agentsest. 2009Pelican TherapeuticsBoca Raton, FL, US · est. 2009

Pelican Therapeutics: Advancing next-gen TNF-based immunotherapy in biotechnology.

Series B · $15.6M4
Palm TherapeuticsPalm TherapeuticsSan Diego, CA, USCancer Treatmentest. 2018Palm TherapeuticsSan Diego, CA, US · est. 2018

Revolutionizing cancer treatment with next-gen root-level therapeutics.

Angel · $991.1k7
PanTher TherapeuticsPanTher TherapeuticsWatertown, MA, USCancer Treatmentest. 2016PanTher TherapeuticsWatertown, MA, US · est. 2016

PanTher Therapeutics: Revolutionizing cancer care with an effective, minimal side-effect treatment platform.

Series B · $21.3M13
G1 TherapeuticsG1 TherapeuticsTriangle (historical), NC, USCancer Therapiesest. 2008G1 TherapeuticsTriangle (historical), NC, US · est. 2008

US-based G1 Therapeutics develops innovative treatments for oncology and breast cancer.

Public · $697.4M170

John Creecy's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuLee Sirg-OoLee Sirg-OoCEO · DunamuIn-hyuk ChoiIn-hyuk ChoiCEO · Naver FinancialWILL WEI CHENGWILL WEI CHENGBoard Member · DiDi

People Similar to John Creecy

Christopher HuntChristopher HuntCEO · Hunt CompaniesH.L. HuntH.L. HuntFounder · Hunt Energy EnterprisesMike PykoszMike PykoszCEO at Hunt ClubRyan DaleyRyan DaleyCo-Founder · Sawatch LabsPhilip BellPhilip BellCEO · Electro-PetroleumWoody L. HuntWoody L. HuntFounder · Hunt Companies